Company Filing History:

32 out of 1,164

Boehringer Mannheim Gmbh

patents

3 out of 480

Roche Diagnostics Gmbh

patents

1 out of 6,662

Hoechst Aktiengesellschaft

patents

Years Active: 1977-2004

Loading Chart...

36 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6689616 - Dye-polysaccharide conjugates and their use as a diagnostic agent (2004-02-10),

2. 6472396 - Barbituric acid derivatives, processes for their production and pharmaceutical agents containing these compounds (2002-10-29),

3. 6110924 - Barbituric acid derivatives, processes for their production and (2000-08-29),

4. 5770593 - Method of determining a pharmaceutical combination preparations for use (1998-06-23),

5. 5627170 - Phosphonic acid compound containing heterocyclic substituents, (1997-05-06),

6. 5578590 - Pharmaceutical composition preparation for use in inhibiting protein (1996-11-26),

7. 5543402 - [3-(C.sub.16 -C.sub.18)-alkanesulphinyl and (1996-08-06),

8. 5538957 - Phosphonosuccinic acid derivatives, processes for their preparation and (1996-07-23),

9. 5369119 - Use of imexon as an immune suppressive and pharmaceutical compositions (1994-11-29),

10. 5366969 - Amidine group containing monocycloheteracyclic or bicycloheterocyclic (1994-11-22),

11. 5206253 - Disphosphonic acid derivatives, processes for their production and (1993-04-27),

12. 5158942 - Process of using phospholipid derivatives to inhibit multiplication of (1992-10-27),

13. 5002937 - Diphosphonic acid compounds and use for calcium metabolism disorders (1991-03-26),

14. 4996219 - Imidazolidine derivatives as immunosuppressives (1991-02-26),

15. 4971958 - Diphosphonic acid derivatives, pharmaceutical compositions and methods (1990-11-20),

Title: Elmar Bosies: Innovator in Diagnostic Agents and Pharmaceuticals

Introduction

Elmar Bosies, based in Weinheim, Germany, is a prominent inventor known for his significant contributions to the fields of pharmaceuticals and diagnostics. With a remarkable portfolio of 36 patents, he has played a vital role in the development of innovative compounds that enhance diagnostic accuracy and therapeutic efficacy.

Latest Patents

Among Elmar Bosies’ latest patents are groundbreaking innovations such as dye-polysaccharide conjugates which serve as diagnostic agents, particularly in determining glomerular filtration rates in humans. Additionally, he has developed barbituric acid derivatives along with processes for their production and pharmaceutical applications, showcasing his expertise in synthetic chemistry and drug development.

Career Highlights

Elmar has built a distinguished career working with leading companies in the diagnostic field, including Boehringer Mannheim GmbH and Roche Diagnostics GmbH. His work at these organizations has not only propelled his career forward but also has had a substantial impact on the industry, as evidenced by his extensive patent portfolio.

Collaborations

Throughout his career, Elmar has collaborated with notable colleagues such as Rudi Gall and Uwe Bicker. These partnerships have enabled him to push the boundaries of research and development, leading to advancements that benefit patients and healthcare professionals alike.

Conclusion

Elmar Bosies stands out as a significant figure in the world of patents and medical innovation. His dedicated work in developing diagnostic agents and pharmaceutical compounds exemplifies the spirit of innovation that drives progress in healthcare. As he continues to push the envelope of scientific discovery, his contributions will undoubtedly lead to further advancements in the industry.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com